A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

Abbvie (ABBV) announced an update on their ongoing clinical study. AbbVie has announced a new clinical study titled ‘A Global Real-World Evidence Study on the ...

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and how to ...

Medical research currently demonstrates that patients with Parkinson's disease can achieve better long-term results through ...

At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile ...

Learn about progressive supranuclear palsy (PSP), a rare brain disorder affecting body movements, balance, and eye movements.

Recent scientific discoveries are challenging traditional views of Parkinson’s disease, suggesting that this neurological condition might actually begin in an unexpected place, the digestive system.